Miromatrix to Report Third Quarter 2021 Financial Results

Rhea-AI Summary

Miromatrix Medical Inc. (NASDAQ: MIRO) will report its third quarter 2021 financial results on November 15, 2021, after market close. A conference call will follow at 3:30 PM CT to discuss these results. Miromatrix specializes in bioengineering fully transplantable organs, focusing on addressing the shortage of human organs. The company is particularly invested in developing human livers and kidneys using its proprietary perfusion technology. Interested parties can participate in the conference call by dialing the provided numbers or joining the live webcast on Miromatrix's investor relations page.

Positive

• Upcoming financial results report on November 15, 2021.
• Focus on bioengineering human organs addresses organ shortage.

Negative

• None.

EDEN PRAIRIE, Minn., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that the Company will report financial results for the third quarter 2021 after market close on Monday, November 15, 2021. Company management will host a corresponding conference call beginning at 3:30 pm Central Time / 4:30 pm Eastern Time.

Individuals interested in listening to the conference call may do so by dialing 844-825-9789 for domestic callers or 412-317-5180 for international callers. Please reference Conference ID: 10161624. To listen to a live webcast, please visit the investor relations section of Miromatrix's website at: https://miromatrix.gcs-web.com/

About Miromatrix

Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com.

Investor Contact
Greg Chodaczek
347-620-7010
ir@miromatrix.com

Media Contact:
press@miromatrix.com

FAQ

When will Miromatrix report its third quarter 2021 financial results?

Miromatrix will report its third quarter 2021 financial results on November 15, 2021.

What time is the Miromatrix conference call on November 15, 2021?

The Miromatrix conference call will begin at 3:30 PM Central Time on November 15, 2021.

What is the focus of Miromatrix's business?

Miromatrix focuses on bioengineering fully transplantable human organs, particularly livers and kidneys.

How can I listen to the Miromatrix conference call?

To listen to the Miromatrix conference call, dial 844-825-9789 for domestic calls or 412-317-5180 for international calls, or join via the live webcast on their investor relations website.